Listen to our experts discuss their real-world experiences of using biomarkers for practical diagnoses – how best can they be applied? What combination is the most useful for personalised treatment? Discover how our experts are additionally using amyloid-targeting treatments in their clinics.
14-08-2024 | Alzheimer's Disease | Panel Discussion | Article | Supported by: Lilly